Non-interventional Study for Determining the Improvement in the Activity Status / Life Quality of Patients With Rheumatoid Arthritis Being Treated With the Tempus Tablet.
Phase of Trial: Phase IV
Latest Information Update: 16 Apr 2014
At a glance
- Drugs Prednisone (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Merck KGaA
- 10 Jun 2017 Biomarkers information updated
- 04 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Aug 2010 Planned end date changed from 1 Mar 2010 to 1 Nov 2010 as reported by ClinicalTrials.gov.